secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2024-01-10T23:59:59+00:00
Accession:  0001801170-24-000043
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health targets Adjusted EBITDA profitability for full-year 2024
----------------------------------------------------------------------

- Targets Adjusted EBITDA profitability for full-year 2024.
- CEO Andrew Toy cites strong 2023 Insurance performance and Clover Assistant technology.
- Plans to focus on member retention rather than expansion in core markets.
- Will issue full-year 2024 guidance at a later date.
- Presentation at 42nd Annual J.P. Morgan Healthcare Conference on Jan 11, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117024000043/0001801170-24-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117024000043/clov-20240110.htm
  HTML page:      https://secwatch.observer/filing/0001801170-24-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer